Workflow
*ST天山(300313) - 2015 Q3 - 季度财报
TIANSHAN BIOTIANSHAN BIO(SZ:300313)2015-10-23 16:00

Financial Performance - Total operating revenue reached CNY 110,800,432.47, a significant increase of 324.86% year-on-year[7] - Net profit attributable to shareholders was a loss of CNY 4,087,767.96, representing a decline of 352.41% compared to the same period last year[7] - The company reported an operating loss of CNY -19,384,306.66, a decline of 747.24% from an operating profit of CNY 2,994,918.35 in the previous year[23] - The net profit attributable to the parent company was CNY -14,219,457.54, a decrease of 327.67% from CNY 6,245,627.91 in the previous year[23] - The company reported a significant increase in prepayments, which rose to CNY 123,585,460.43 from CNY 826,122.50, indicating a substantial growth[51] - The company reported a comprehensive income total of -¥32,295,051.30 for the current period, contrasting with ¥6,866,821.39 in the previous period[68] Assets and Liabilities - Total assets increased by 35.85% to CNY 828,674,123.48 compared to the end of the previous year[7] - Total liabilities increased to CNY 392,187,809.89 from CNY 173,575,443.57, showing a growth of approximately 126.5%[53] - The company's equity attributable to shareholders decreased to CNY 370,212,687.14 from CNY 395,245,973.90, a decline of about 6.3%[54] - Current assets totaled CNY 462,136,494.91, up from CNY 308,823,511.38, indicating a rise of about 49.5%[51] - The company's long-term investments decreased from CNY 197,084,180.00 to CNY 159,434,180.00, reflecting a decline of approximately 19.1%[55] Cash Flow - The net cash flow from operating activities showed a drastic improvement, with a negative value of CNY 131,980,825.94, reflecting a 2,991.20% change from the previous year[7] - Cash inflow from financing activities increased by 242.68% to 251.25 million yuan, primarily due to increased bank loans[28] - The net cash flow from operating activities was -131,980,825.94 CNY, a significant decline compared to -4,269,563.86 CNY in the previous period, indicating a worsening operational performance[74] - The total cash outflow from operating activities was 342,143,392.52 CNY, compared to 190,280,577.66 CNY in the previous period, indicating increased operational costs[74] Revenue Sources - Sales revenue from breeding livestock amounted to 82.23 million yuan, up 1063.28% year-on-year, while meat product sales revenue increased by 207.36% to 18.08 million yuan[27] - The proportion of breeding livestock sales in total revenue rose by 40.8 percentage points to 50.99%[28] - The company experienced a 53.38% decrease in government subsidies recognized as non-operating income[28] Investments and Acquisitions - The company completed the acquisition of Mingahai Ranch assets in Victoria, Australia, positioning it as a breeding base, aiming to enhance profitability and market layout[14] - The project for bull semen production and research has received CNY 4,152.15 million, with CNY 1,546.24 million invested in the current period, achieving 52.98% of the planned progress[35] - The acquisition of Australian assets has been fully completed with a total investment of CNY 5,294.33 million, achieving 100% of the planned investment[35] Risk Management - The company faces risks related to seasonal fluctuations in revenue due to reliance on government procurement for sales[12] - The company emphasizes risk management in overseas investments, particularly regarding policy changes and market conditions[14] - The company is aware of exchange rate risks due to fluctuations in the AUD/CNY exchange rate and is taking measures to mitigate these risks[15] Shareholder Information - The total number of shareholders at the end of the reporting period was 8,092[17] - The company holds a 30.00% stake (56,080,000 shares) in the top shareholder, Tianshan Animal Husbandry Development Co., Ltd., with 26,210,996 shares pledged[18] - The chairman and senior management increased their shareholding by a total of 922,900 shares, raising their collective ownership from 1.88% to 2.37%[47] Future Plans - The company plans to expand its market share through product line diversification and vertical integration of the industry chain[10] - The company plans to enhance internal controls and performance evaluation mechanisms to mitigate management risks[14] - The company plans to accelerate live cattle introduction and capitalize on the winter sales peak for beef and lamb products in the fourth quarter[28]